Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders June 30, 2022
Exro Announces Executive Chairman Stepping Down and Appointment of Interim Chairman Rod Copes April 6, 2023